͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏
| | | | Thank you to everyone who fed into our policy research on global collaboration. Your insights paint a picture of delays, higher research and visa costs as well as more complexity around data and sample sharing.
Eight in ten researchers said that since the UK left the EU it has been harder to begin new collaborations with EU-based scientists.
The evidence you’ve provided strengthens our policy calls and is sparking important conversations with the UK government.
Using your evidence, we’ve set out four recommendations for more effective UK/EU collaboration: |
| | Avoid duplication in clinical trial set-up and reduce red tape and costs through a mutual recognition agreement. Support global research programmes and play an active role in shaping conversations about research priorities. Reduce trade friction to ensure scientists can access items needed for research in a timely manner. Ensure data flows between environments that maintain equivalent standards. | | |
|
|
|
|
|
Funding & Research Opportunities |
| Get in touch with our office for confidential advice on eligibility, remit and funding options prior to applying. |
|
| | | | | | | | | | | | | | | | | | | | | | Applications accepted all year round |
|
|---|
| | | | | | Applications accepted all year round |
|
|---|
|
| | |
|
|
Last chance to become our April #ResearchIsBeautiful pick |
| Don’t forget to send us your images for a chance to be chosen as this month’s Research is Beautiful winner.
We’ve had an outstanding response to the campaign so far, you’ve sent us images of your microscopy, images of you and your fellow researchers at work, and even some of you sharing your science with the public.
We’d love to see your take on the beauty of cancer research. Send your images to researcher.comments@cancer.org.uk by tomorrow, 25 April at 11:59pm to be considered.
Needing inspiration? Check out the entries from our past winners. |
| | |
|
|
|
| | | | | Our innovation arm, Cancer Research Horizons has partnered with Histofy to develop AI tools to stratify colorectal cancer patients.
Histofy will use the S:CORT dataset of clinically linked multi-omics data to develop and validate its AI models that stratify patients based on their likelihood of progressive disease and response to therapy. | | |
| | | | | | | Three years after launching our innovation arm, the team at Cancer Research Horizons would like to hear about your experiences working with them.
Your insights will help enhance their work and the ways in which they support the translational research community.
The survey should take around 10 minutes to complete. All responses are confidential.
The survey closes on 9 May. | | |
|
|---|
|
|
|
|
| | It’s becoming clear that small insertion and deletion (InDels) mutations are numerous and potentially important in cancer.
Recent studies have shown 18 InDel signatures associated with human cancers, and now a team led by Serena Nik-Zainal have developed a new tool – a classification system – to look in greater depth at InDels.
The greater accuracy of the system is not only important biologically, but also clinically, says Nik-Zainal. |
| | |
|
|
|
| | | | | Ahead of this year’s Cancer Prevention Research Conference on 25-27 June, our City of London Centre will be hosting a one-day Primer on Cancer Prevention.
This in-person workshop on 24 June is for anyone who wants to learn the fundamentals of cancer prevention from experts in the field, ready to dive into the scientific sessions and thought-provoking debates on the latest prevention research at our conference.
Register today to join co-hosts Peter Sasieni (Wolfson Institute of Population Health), Olivera Finn (University of Pittsburgh), Philip Castle and Jessica Faupel-Badger (National Cancer Institute) in London this summer. | | |
| | | | | | | The 2025 Annual Congress of the European Association for Cancer Research (EACR 2025) will be taking place on 16-19 June in Lisbon, Portugal. The four-day congress will cover a wide breadth of topics across basic, preclinical and translational cancer research.
Early rate registration closes on 28 April so be sure to secure your place soon and take advantage of the discounted rate. | | |
|
|---|
|
|
|
|
Stay informed with NICE News for Life Sciences |
| Keep up to date with the latest developments from the National Institute for Health and Care Excellence (NICE). NICE’s dedicated newsletter for the life sciences sector delivers essential insights straight to your inbox.
You’ll receive timely updates on the latest NHS access initiatives, international research projects and developments in healthcare decision-making that could impact your research. Sign up today for the latest information on NICE’s support services, upcoming webinars and events, and ways to connect with NICE. |
| | |
|
|
|
| | Together we are
beating cancer |
| | |
|---|
|
|
|
| | | You are playing a crucial role in helping us beat cancer, so we'd like to continue to keep you updated on what we're up to. You can manage your preferences and unsubscribe here.
Your details are safe with us. Check out our Privacy Policy.
Our supporters are at the heart of everything we achieve at Cancer Research UK. Read our Fundraising Promise.
This email is from Cancer Research UK. Cancer Research UK is a registered charity in England and Wales (1089464), Scotland (SC041666), the Isle of Man (1103) and Jersey (247). A company limited by guarantee. Registered company in England and Wales (4325234) and the Isle of Man (5713F). Registered address: 2 Redman Place, London, E20 1JQ. |
|
|
|
